In another research on HUVECs, GDM displayed higher levels of miR-30c-5p, miR-452-5p, miR-126-3p, miR-130b-3p, and miR-148a-3p, which inhibited the expression of AMP-activated protein kinase-α1 (AMPKα1) and decreased fatty-acid oxidation (174). This evidence concerns the gene PRKAA1 and gestational diabetes.